Early-Life Intestine Microbiota and Lung Health in Children

Area of Science:

• Microbiology
• Pediatric Health
• Pulmonology

Background:

• The gastrointestinal microbiota is crucial for infant nutrition, metabolism, and immunity.
• Gut microbiota development occurs within the first 1-3 years of life and impacts long-term health.
• Intestinal dysbiosis is linked to chronic lung disease progression.

Purpose of the Study:

• To review recent research on the gut-lung axis in infants and children.
• To explore the effects of targeting gut microbiota in pediatric lung diseases.
• To identify critical intervention windows for improving long-term lung health.

Main Methods:

• Literature review of recent studies on gut microbiota and lung health.
• Focus on research involving infants and children at risk of or with progressive lung diseases.
• Analysis of the gut-lung axis and microbiota-targeted interventions.

Main Results:

• The gut microbiota significantly impacts infant development and future lung health.
• Early-life gut microbiota interventions show promise for managing pediatric lung diseases.
• Targeting the gut microbiota during the establishment phase offers the best potential for health control.

Conclusions:

• Understanding the gut-lung axis is key to developing novel therapeutic strategies.
• Early interventions targeting the infant gut microbiota can mitigate chronic lung disease progression.
• Exploiting the critical window of early life microbiota development is essential for long-term health benefits.